Code System: CDCNHSN

OID: 2.16.840.1.113883.6.277
Name: NHSN Surveillance System Codes (CDCNHSN)
Definition: A set of healthcare surveillance vocabulary concepts and associated identifiers intended solely for data submissions to the National Healthcare Safety Network (NHSN). Other uses are not recommended.
Version: 2020-07


NHSN Surveillance System Codes (CDCNHSN)
Code Description
2350-2 A new antimicrobial agent(s) is started, and is continued for >=4 days
2105-5 Abdominal aortic aneurysm repair
2107-1 Abdominal hysterectomy
2118-8 Abdominal surgery
1309-4 Active surgical site infection (SSI) detection method
1871-3 Active surveillance testing (AST) eligible patients
3193-0 Active surveillance testing (AST) organism monitored
1957-0 Acute onset of diarrhea (liquid stools for >12 hours)
1971-1 Acute pain, swelling, or tenderness of testes, epididymis, or prostate
1510-7 Admission (during the stay in which the surgery was performed)
1652-7 Admitting inpatient facility
2368-9 Adult students or trainees and volunteers
2301-0 All patients
1965-3 Allogeneic hematopoietic stem cell transplant (allo-SCT) with diarrhea
1964-6 Allogeneic hematopoietic stem cell transplant (allo-SCT) with grade >=3 gastrointestinal graft-versus-host disease (GI GVHD)
1205-4 Anterior and posterior
6140-8 Antimicrobial-coated catheter used
1959-6 Apnea, tachypnea, nasal flaring with retraction of chest wall or grunting
2108-9 Appendix surgery
1623-8 Arterial or venous infection
2402-6 Asymptomatic bacteremic UTI (ABUTI)
1101-5 Atlas-axis
1102-3 Atlas-axis/Cervical
3061-9 Atrial lines (right and left)
1651-9 Attending physician other than surgeon
2037-0 Bacterial isolate tested for carbapenemase
2513-0 Bilateral infiltrates on chest x-ray
2109-7 Bile duct, liver or pancreatic surgery
3302-7 Birth weight 1001-1500 grams
3303-5 Birth weight 1501-2500 grams
3301-9 Birth weight 751-1000 grams
3304-3 Birth weight over 2500 grams
3300-1 Birth weight under 750 grams
1902-6 Blood culture not done or no organisms detected in blood
2500-7 Blood product was implicated in the adverse reaction
2339-0 Blood sample collected for culture
1798-8 Bone or joint infection
1908-3 Bradycardia or tachycardia
1601-4 Breast abscess or mastitis
2110-5 Breast surgery
1671-7 Bronchitis or tracheitis
1672-5 Burn infection
2308-5 Buttonhole cannulation
2029-7 C. difficile primary testing method used most often for this quarter
1795-4 C. difficile-associated disease (CDAD) infection
6122-6 Cap
2045-3 Carba NP
2049-5 Carbapenemase type
2111-3 Cardiac surgery
2114-7 Carotid endarterectomy
2501-5 Case definition match
1969-5 Catheter-graft hybrid
2031-3 Cell cytotoxicity neutralization assay
1002-5 Central line
3121-1 Central line exchanged over guidewire
1006-6 Central line including umbilical catheter
3108-8 Central line insertion practice (CLIP)
2016-4 CephR-Klebsiella
1103-1 Cervical
1104-9 Cervical/Dorsal/Dorsolumbar
2115-4 Cesarean section
1603-0 Clinical sepsis
3195-5 Clinical specialty
2116-2 Colon surgery
1944-8 Common commensal from >=2 blood cultures
3070-0 Common commensal from blood specimen(s) and antibiotics for >=5 days
3072-6 Common commensal from cerebrospinal fluid specimen and antibiotics for >=5 days
2303-6 Contamination
2337-4 Continuation of antimicrobial
6130-9 Contraindication type
1325-0 Cooperative infection prevention process between facilities
2112-1 Coronary artery bypass graft with both chest and donor site incisions
2113-9 Coronary artery bypass graft with chest incision only
2117-0 Craniotomy
2018-0 CRE-E. coli
2019-8 CRE-Enterobacter
2017-2 CRE-Klebsiella
2352-5 Criterion 1: positive culture from bronchoalveolar lavage without purulent respiratory secretions
2351-1 Criterion 1: positive culture from endotracheal aspirate without purulent respiratory secretions
2353-3 Criterion 1: positive culture from lung tissue without purulent respiratory secretions
2354-1 Criterion 1: positive culture from protected specimen brush without purulent respiratory secretions
2358-0 Criterion 2: organisms from bronchoalveolar lavage culture with purulent respiratory secretions
2357-2 Criterion 2: organisms from endotracheal aspirate culture with purulent respiratory secretions
2359-8 Criterion 2: organisms from lung tissue culture with purulent respiratory secretions
2360-1 Criterion 2: organisms from protected specimen brush culture with purulent respiratory secretions
2356-4 Criterion 2: organisms from sputum culture with purulent respiratory secretions
2355-9 Criterion 2: purulent respiratory secretions plus organism(s)
2363-2 Criterion 3: positive diagnostic test for Legionella species
2364-0 Criterion 3: positive diagnostic test for selected viral pathogens
2362-4 Criterion 3: positive test for lung histopathology
2361-0 Criterion 3: positive test for organism(s) identified from pleural fluid
2516-3 Criterion not otherwise specified
2346-5 Daily minimum FiO2 increase >=0.20 (20 points) for >=2 days
2347-3 Daily minimum PEEP increase >=3 cm H2O for >=2 days
1373-0 Date first admitted to facility
1673-3 Decubitus ulcer infection
1604-8 Deep incisional primary surgical site infection (SSI)
1605-5 Deep incisional secondary surgical site infection (SSI)
2333-3 Dialysis clinic
2514-8 Diffuse hemorrhage
1674-1 Disseminated infection
1105-6 Dorsal/Dorsolumbar
1607-1 Ear or mastoid infection (otitis externa, otitis media, otitis interna, mastoiditis)
2366-3 Employees (staff on facility payroll)
2030-5 Enzyme immunoassay (EIA) for toxin
3057-7 Epidermolysis bullosa during current admission
1334-2 Extremely preterm (<28 weeks)
1608-9 Eye infection, other than conjunctivitis
6133-3 Facility restrictions or safety concerns for chlorhexidine gluconate use in premature infants precludes its use
3542-8 Facility transfuses blood products treated with pathogen reduction technology
4103-8 Fellow
3498-3 First discovery
1938-0 Fourfold rise in Legionella pneumophila antibody titer
1935-6 Fourfold rise in paired sera for pathogen
1940-6 Fungi or Pneumocystis carinii from lower respiratory tract specimen
2119-6 Gallbladder surgery
2120-4 Gastric surgery
1609-7 Gastrointestinal tract infection (esophagus, stomach, small and large bowel, and rectum) excluding gastroenteritis and appendicitis
2033-9 Glutamate dehydrogenase (GDH) antigen plus enzyme immunoassay (EIA) for toxin
2035-4 Glutamate dehydrogenase (GDH) plus enzyme immunoassay (EIA) for toxin, followed by nucleic acid amplification test (NAAT) for discrepant results
2034-7 Glutamate dehydrogenase (GDH) plus nucleic acid amplification test (NAAT)
1929-9 Greater than or equal to 2 positive urine cultures with >=100 cfu/ml of same uropathogen from non-voided specimen
1931-5 Greater than or equal to 2 positive urine cultures with >=100,000 cfu/ml with no more than 2 organisms
1923-3 Greater than or equal to 5% bronchoalveolar lavage cells with bacteria
3109-6 Hand hygiene
2121-2 Heart transplant
3062-7 Hemodialysis reliable outflow (HERO) catheter
2543-7 Hemovigilance module – monthly reporting denominator
2106-3 Herniorrhaphy
2101-4 Hip prosthesis
1956-2 Histopathologic exam with abscess formation or lung parenchyma invasion by fungal hyphae
2332-5 Hospital (on the day of or the day following admission) or Emergency Department
1645-1 Hospital transfer/admission
1416-7 HPRO: Hemi: Partial Primary
1418-3 HPRO: Hemi: Partial Revision
1417-5 HPRO: Hemi: Total Revision
1421-7 HPRO: Resurfacing: Partial Primary
1422-5 HPRO: Resurfacing: Partial Revision
1419-1 HPRO: Resurfacing: Total Primary
1420-9 HPRO: Resurfacing: Total Revision
1415-9 HPRO: Total: Partial Revision
1413-4 HPRO: Total: Total Primary
1414-2 HPRO: Total: Total Revision
1924-0 Imaging test evidence of infection
2052-9 Imipenemase
2502-3 Imputability of adverse reaction to transfusion
2503-1 Imputability of death to transfusion
2307-7 Imputability of positive blood culture to suspected source
1967-9 Incision deliberately opened or drained
1675-8 Infant pustulosis
1656-8 Infection first reported source
3188-0 Infection occurred post-procedure
1797-0 Infection of the ear, eyes, nose, or throat
1237-7 Infection present at time of surgery (PATOS)
2344-2 Infection-related ventilator-associated complication (IVAC)
1610-5 Intraabdominal infection, not specified elsewhere including gallbladder, bile ducts, liver (excluding viral hepatitis), spleen, pancreas, peritoneum, subphrenic or subdiaphragmatic space, or other intraabdominal tissue or area not specified elsewhere
3063-5 Intra-aortic balloon pump (IABP) device
1611-3 Intracranial infection (brain abscess, subdural or epidural infection, encephalitis)
2306-9 Intravenous injection of antifungal substance
2048-7 Isolate tested positive for carbapenemase
4100-4 IV team
1612-1 Joint or bursa infection
2122-0 Kidney surgery
2123-8 Kidney transplant
2050-3 Klebsiella pneumoniae carbapenemase
2124-6 Knee prosthesis
3055-1 Known or suspected Munchausen syndrome by proxy during current admission
1409-2 KPRO: Hemi: Partial Primary
1412-6 KPRO: Hemi: Partial Revision
1411-8 KPRO: Hemi: Total Revision
1408-4 KPRO: Total: Partial Revision
1406-8 KPRO: Total: Total Primary
1407-6 KPRO: Total: Total Revision
1613-9 Laboratory-confirmed bloodstream infection
2125-3 Laminectomy
6112-7 Large sterile drape
3002-3 Last physical overnight location of patient immediately prior to arriving into facility
1937-2 Legionella pneumophila serogroup 1 antigens in urine
2367-1 Licensed independent practitioners: physicians, advanced practice nurses, and physician assistants
2126-1 Limb amputation
2127-9 Liver transplant
1920-8 Localized swelling
2341-2 Location of mechanical ventilation initiation
2325-9 Loss of vascular access
1106-4 Lumbar/Lumbosacral
6110-1 Mask
1939-8 Matching positive blood and sputum cultures with Candida species
2010-7 MDR-Acinetobacter
2318-4 MDRO or C. difficile infection
4102-0 Medical staff not otherwise specified
1615-4 Meningitis or ventriculitis
2046-1 Metallo-beta-lactamase gradient strip
2047-9 Metallo-beta-lactamase screen
1336-7 Moderate to late preterm (32 to <37 weeks)
2044-6 Modified Hodge test
1942-2 More than 15 colonies cultured from intravascular cannula tip using semi-quantitative culture method
1792-1 Multi-drug resistant organism (MDRO) infection
1602-2 Myocarditis or pericarditis
2515-5 Nausea/vomiting
2128-7 Neck surgery
3066-8 Neonatal Laboratory Confirmed Bloodstream Infection 1 (NLCBI 1)
3067-6 Neonatal Laboratory Confirmed Bloodstream Infection 2 (NLCBI 2)
3068-4 Neonatal Laboratory Confirmed Meningitis 1 (NLCM 1)
3069-2 Neonatal Laboratory Confirmed Meningitis 2 (NLCM 2)
2336-6 New antibiotic start
2051-1 New Delhi metallo-beta-lactamase
1907-5 New onset or change in sputum, increased secretions or increased suctioning
1903-4 New onset/change in sputum
1904-2 New onset/worsening cough, dyspnea, tachypnea
1925-7 New or progressive and persistent infiltrate
2335-8 New outpatient start or continuation of inpatient course
1676-6 Newborn circumcision infection
3540-2 No hemovigilance adverse reactions reported this month
3541-0 No hemovigilance incidents reported this month
1311-0 No location change
3119-7 No pathogen identified
1340-9 No same day outcome measures (events) reported this month
3064-3 Non-accessed central line (not accessed nor inserted during the hospitalization)
3189-8 Non-autologous transplant
2055-2 Nonspecific carbapenemase activity
2056-0 Nonspecific metallo-beta-lactamase activity
1119-7 Non-tunneled (dialysis)
1120-5 Non-tunneled (other than dialysis)
2103-0 Not an NHSN operation
1901-8 Not cultured
2032-1 Nucleic acid amplification test (NAAT)
2057-8 Nucleic acid amplification test (NAAT) plus enzyme immunoassay (EIA), if NAAT positive (2-step algorithm)
1862-2 Number of admissions
1831-7 Number of admissions adjusted for C. difficile reporting
1828-3 Number of admissions adjusted for MDRO reporting (for inpatient location)
1371-4 Number of admissions on C. difficile treatment
1641-0 Number of admissions with an order for a prophylactic intravenous antibiotic that was administered on time
1642-8 Number of admissions with an order for a prophylactic intravenous antibiotic that was not administered on time
1643-6 Number of admissions with no order for a prophylactic intravenous antibiotic
3499-1 Number of adverse reactions
1834-1 Number of airway pressure release ventilation (APRV) days
3533-7 Number of aliquots transfused: Plasma: Apheresis: Psoralen-treated
3536-0 Number of aliquots transfused: Plasma: Apheresis: Riboflavin-treated
3524-6 Number of aliquots transfused: Plasma: Whole blood-derived: Psoralen-treated
3527-9 Number of aliquots transfused: Plasma: Whole blood-derived: Riboflavin-treated
3424-9 Number of aliquots transfused: Platelets: Apheresis: Irradiated
3428-0 Number of aliquots transfused: Platelets: Apheresis: Irradiated or leukocyte-reduced
3426-4 Number of aliquots transfused: Platelets: Apheresis: Leukocyte-reduced
3492-6 Number of aliquots transfused: Platelets: Apheresis: Not irradiated or leukocyte-reduced
3515-4 Number of aliquots transfused: Platelets: Apheresis: Psoralen-treated
3569-1 Number of aliquots transfused: Platelets: Apheresis: Psoralen-treated and in plasma
3572-5 Number of aliquots transfused: Platelets: Apheresis: Psoralen-treated and in platelet additive solution
3518-8 Number of aliquots transfused: Platelets: Apheresis: Riboflavin-treated
3575-8 Number of aliquots transfused: Platelets: Apheresis: Riboflavin-treated and in plasma
3578-2 Number of aliquots transfused: Platelets: Apheresis: Riboflavin-treated and in platelet additive solution
3412-4 Number of aliquots transfused: Red Blood Cells: Apheresis: Irradiated
3416-5 Number of aliquots transfused: Red Blood Cells: Apheresis: Irradiated or leukocyte-reduced
3414-0 Number of aliquots transfused: Red Blood Cells: Apheresis: Leukocyte-reduced
3479-3 Number of aliquots transfused: Red Blood Cells: Apheresis: Not irradiated or leukocyte-reduced
3560-0 Number of aliquots transfused: Red Blood Cells: Apheresis: Riboflavin-treated
3557-6 Number of aliquots transfused: Red Blood Cells: Apheresis: S-303-treated
3404-1 Number of aliquots transfused: Red Blood Cells: Whole blood-derived: Irradiated
3408-2 Number of aliquots transfused: Red Blood Cells: Whole blood-derived: Irradiated and leukocyte-reduced
3406-6 Number of aliquots transfused: Red Blood Cells: Whole blood-derived: Leukocyte-reduced
3472-8 Number of aliquots transfused: Red Blood Cells: Whole blood-derived: Not irradiated or leukocyte-reduced
3551-9 Number of aliquots transfused: Red Blood Cells: Whole blood-derived: Riboflavin-treated
3548-5 Number of aliquots transfused: Red Blood Cells: Whole blood-derived: S-303-treated
2409-1 Number of blood cultures performed
1372-2 Number of C. difficile treatment starts
1833-3 Number of central line days
1854-9 Number of central line days including umbilical catheter
2310-1 Number of chronic hemodialysis patients: fistula
2312-7 Number of chronic hemodialysis patients: graft
2314-3 Number of chronic hemodialysis patients: non-tunneled central line
2315-0 Number of chronic hemodialysis patients: other access device
2313-5 Number of chronic hemodialysis patients: tunneled central line
3565-9 Number of discards: Cryoprecipitate: Psoralen-treated
3567-5 Number of discards: Cryoprecipitate: Riboflavin-treated
3534-5 Number of discards: Plasma: Apheresis: Psoralen-treated
3537-8 Number of discards: Plasma: Apheresis: Riboflavin-treated
3525-3 Number of discards: Plasma: Whole blood-derived: Psoralen-treated
3528-7 Number of discards: Plasma: Whole blood-derived: Riboflavin-treated
3494-2 Number of discards: Platelets: Apheresis: Irradiated
3496-7 Number of discards: Platelets: Apheresis: Irradiated or leukocyte-reduced
3495-9 Number of discards: Platelets: Apheresis: Leukocyte-reduced
3493-4 Number of discards: Platelets: Apheresis: Not irradiated or leukocyte-reduced
3516-2 Number of discards: Platelets: Apheresis: Psoralen-treated
3570-9 Number of discards: Platelets: Apheresis: Psoralen-treated and in plasma
3573-3 Number of discards: Platelets: Apheresis: Psoralen-treated and in platelet additive solution
3519-6 Number of discards: Platelets: Apheresis: Riboflavin-treated
3576-6 Number of discards: Platelets: Apheresis: Riboflavin-treated and in plasma
3579-0 Number of discards: Platelets: Apheresis: Riboflavin-treated and in platelet additive solution
3487-6 Number of discards: Platelets: Whole blood-derived: Irradiated
3489-2 Number of discards: Platelets: Whole blood-derived: Irradiated and leukocyte-reduced
3488-4 Number of discards: Platelets: Whole blood-derived: Leukocyte-reduced
3486-8 Number of discards: Platelets: Whole blood-derived: Not irradiated or leukocyte-reduced
3507-1 Number of discards: Platelets: Whole blood-derived: Psoralen-treated
3510-5 Number of discards: Platelets: Whole blood-derived: Riboflavin-treated
3481-9 Number of discards: Red Blood Cells: Apheresis: Irradiated
3483-5 Number of discards: Red Blood Cells: Apheresis: Irradiated or leukocyte-reduced
3482-7 Number of discards: Red Blood Cells: Apheresis: Leukocyte-reduced
3480-1 Number of discards: Red Blood Cells: Apheresis: Not irradiated or leukocyte-reduced
3561-8 Number of discards: Red Blood Cells: Apheresis: Riboflavin-treated
3558-4 Number of discards: Red Blood Cells: Apheresis: S-303-treated
3474-4 Number of discards: Red Blood Cells: Whole blood-derived: Irradiated
3476-9 Number of discards: Red Blood Cells: Whole blood-derived: Irradiated and leukocyte-reduced
3475-1 Number of discards: Red Blood Cells: Whole blood-derived: Leukocyte-reduced
3473-6 Number of discards: Red Blood Cells: Whole blood-derived: Not irradiated or leukocyte-reduced
3552-7 Number of discards: Red Blood Cells: Whole blood-derived: Riboflavin-treated
3549-3 Number of discards: Red Blood Cells: Whole blood-derived: S-303-treated
1863-0 Number of encounters
1832-5 Number of encounters adjusted for C. difficile reporting
1829-1 Number of encounters adjusted for MDRO reporting
1333-4 Number of episodes of mechanical ventilation (EMV) days
2311-9 Number of fistula patients who undergo buttonhole cannulation
1878-8 Number of incident cases identified by monitoring (clinical positive)
1826-7 Number of new episodes of mechanical ventilation (EMV)
1867-1 Number of observations in which gown and gloves were used
1864-8 Number of observations in which hand hygiene was indicated
1865-5 Number of observations in which hand hygiene was performed
1866-3 Number of observations in which the use of gown and gloves was indicated
1851-5 Number of patient days
1830-9 Number of patient days adjusted for C. difficile reporting (for inpatient location)
1827-5 Number of patient days adjusted for MDRO reporting (for inpatient location)
3436-3 Number of patient samples collected for type and screen or crossmatch
2525-4 Number of patient-present days
1872-1 Number of patients eligible for monitoring at admission/transfer in
1874-7 Number of patients eligible for monitoring at discharge/transfer out
1860-6 Number of patients meeting high risk criteria and offered influenza vaccination but declining because of having medical contraindication
1858-0 Number of patients meeting high risk criteria and previously vaccinated for influenza during current influenza season
1861-4 Number of patients meeting high risk criteria and receiving vaccination during admission
1856-4 Number of patients meeting high risk criteria for influenza vaccination
1859-8 Number of patients meeting high risk criteria for influenza vaccination and offered influenza vaccination but declining for reasons other than medical contraindication
1873-9 Number of patients on which monitoring was performed at admission/transfer in
1875-4 Number of patients on which monitoring was performed at discharge/transfer out
1857-2 Number of patients previously vaccinated for influenza during current influenza season
3306-8 Number of permanent central line days
1876-2 Number of prevalent cases identified by monitoring (clinical positive)
1877-0 Number of prevalent cases previously known
3305-0 Number of temporary central line days
2524-7 Number of therapy days
1889-5 Number of total facility admissions (for inpatient location)
1890-3 Number of total facility encounters (for outpatient location)
1888-7 Number of total facility patient days (for inpatient location)
3564-2 Number of units transfused: Cryoprecipitate: Psoralen-treated
3566-7 Number of units transfused: Cryoprecipitate: Riboflavin-treated
3532-9 Number of units transfused: Plasma: Apheresis: Psoralen-treated
3535-2 Number of units transfused: Plasma: Apheresis: Riboflavin-treated
3523-8 Number of units transfused: Plasma: Whole blood-derived: Psoralen-treated
3526-1 Number of units transfused: Plasma: Whole blood-derived: Riboflavin-treated
3423-1 Number of units transfused: Platelets: Apheresis: Irradiated
3427-2 Number of units transfused: Platelets: Apheresis: Irradiated or leukocyte-reduced
3425-6 Number of units transfused: Platelets: Apheresis: Leukocyte-reduced
3491-8 Number of units transfused: Platelets: Apheresis: Not irradiated or leukocyte-reduced
3514-7 Number of units transfused: Platelets: Apheresis: Psoralen-treated
3568-3 Number of units transfused: Platelets: Apheresis: Psoralen-treated and in plasma
3571-7 Number of units transfused: Platelets: Apheresis: Psoralen-treated and in platelet additive solution
3517-0 Number of units transfused: Platelets: Apheresis: Riboflavin-treated
3574-1 Number of units transfused: Platelets: Apheresis: Riboflavin-treated and in plasma
3577-4 Number of units transfused: Platelets: Apheresis: Riboflavin-treated and in platelet additive solution
3418-1 Number of units transfused: Platelets: Whole blood-derived: Irradiated
3420-7 Number of units transfused: Platelets: Whole blood-derived: Irradiated and leukocyte-reduced
3419-9 Number of units transfused: Platelets: Whole blood-derived: Leukocyte-reduced
3485-0 Number of units transfused: Platelets: Whole blood-derived: Not irradiated or leukocyte-reduced
3505-5 Number of units transfused: Platelets: Whole blood-derived: Psoralen-treated
3508-9 Number of units transfused: Platelets: Whole blood-derived: Riboflavin-treated
3411-6 Number of units transfused: Red Blood Cells: Apheresis: Irradiated
3415-7 Number of units transfused: Red Blood Cells: Apheresis: Irradiated or leukocyte-reduced
3413-2 Number of units transfused: Red Blood Cells: Apheresis: Leukocyte-reduced
3478-5 Number of units transfused: Red Blood Cells: Apheresis: Not irradiated or leukocyte-reduced
3559-2 Number of units transfused: Red Blood Cells: Apheresis: Riboflavin-treated
3556-8 Number of units transfused: Red Blood Cells: Apheresis: S-303-treated
3403-3 Number of units transfused: Red Blood Cells: Whole blood-derived: Irradiated
3407-4 Number of units transfused: Red Blood Cells: Whole blood-derived: Irradiated and leukocyte-reduced
3405-8 Number of units transfused: Red Blood Cells: Whole blood-derived: Leukocyte-reduced
3471-0 Number of units transfused: Red Blood Cells: Whole blood-derived: Not irradiated or leukocyte-reduced
3550-1 Number of units transfused: Red Blood Cells: Whole blood-derived: Riboflavin-treated
3547-7 Number of units transfused: Red Blood Cells: Whole blood-derived: S-303-treated
1853-1 Number of urinary catheter days
1852-3 Number of ventilator days
3005-6 Nursing Home/Skilled Nursing Facility
3056-9 Observed or suspected patient injection into vascular line(s) within the BSI infection window
1909-1 Occult or gross blood in stools (with no rectal fissure)
2202-0 On admission and on discharge/transfer
2201-2 On admission only
1930-7 One positive culture with <=100,000 cfu/ml of a single uropathogen in patient being treated with an effective antimicrobial agent for UTI
2403-4 One positive culture with >=1,000 cfu/ml and <100,000 cfu/ml with no more than 2 species of microorganisms
1927-3 One positive culture with >=100,000 cfu/ml with no more than 2 species of microorganisms
2302-8 Only patients with no prior documentation of colonization or infection
2129-5 Open reduction of fracture
1616-2 Oral cavity infection (mouth, tongue, or gums)
1650-1 Order for prophylactic intravenous antibiotic not administered on time
1640-2 Organ/space
1946-3 Organism(s) identified from pleural fluid
2369-7 Other contract personnel
1905-9 Other evidence of infection found
1614-7 Other infections of lower respiratory tract, other than pneumonia
1617-0 Other infections of the male or female reproductive tract (epididymis, testes, prostate, vagina, ovaries, uterus, or other deep pelvic tissues, excluding endometritis or vaginal cuff infections)
1618-8 Other infections of the urinary tract (kidney, ureter, bladder, urethra, or tissue surrounding the retroperitoneal or perinephric space)
3006-4 Other inpatient healthcare setting (e.g., Acute Care Hospital, LTAC, Rehabilitation, etc.)
2104-8 Other operations
1941-4 Other positive laboratory tests
1906-7 Other signs and symptoms
2407-5 Other than primary
2130-3 Ovarian surgery
2054-5 Oxacillinase-48-like
2131-1 Pacemaker surgery
2517-1 Pain not otherwise specified
1960-4 Pain or tenderness
1312-8 Passive surgical site infection (SSI) detection method
3004-9 Patient discharged from another facility in the past 4 weeks
6132-5 Patient has a documented/known allergy/reaction to chlorhexidine gluconate-based products that would preclude its use
6131-7 Patient is less than 2 months of age – chlorhexidine gluconate is to be used with caution in patients less than 2 months of age
2342-6 Patient on airway pressure release ventilation (APRV) or a related mode of mechanical ventilation at the time of VAE
1326-8 Patient or caregiver contacts facility to report
1654-3 Patient or family member
1327-6 Patient returns to outpatient facility for follow-up
2041-2 PCR: Imipenemase
2039-6 PCR: Klebsiella pneumoniae carbapenemase
2040-4 PCR: New Delhi metallo-beta-lactamase
2043-8 PCR: Oxacillinase-48 like
2042-0 PCR: Verona integron-encoded metallo-beta-lactamase
2213-7 Performer was a member of PICC/IV team
3163-3 Performs direct patient care
3060-1 Peripheral intravenous or midline catheter
2132-9 Peripheral vascular bypass surgery
3115-3 Peripherally inserted central catheter (PICC)
1970-3 Periprosthetic joint infection
1003-3 Permanent central line
3007-2 Personal residence/residential care
4101-2 Physician assistant
1963-8 Physician diagnosis of this event type
1962-0 Physician institutes appropriate antimicrobial therapy
2212-9 PICC team
1926-5 Pneumatoceles (in <=1 year old)
1626-1 Pneumonia 1 (PNU1)
1631-1 Pneumonia 2 (PNU2)
1632-9 Pneumonia 3 (PNU3)
1955-4 Positive blood culture
1952-1 Positive culture
1966-1 Positive culture from >=2 separate tissue or fluid samples from affected joint
1953-9 Positive culture of pathogen
1954-7 Positive culture of skin contaminant
1948-9 Positive culture of virus or Chlamydia
1936-4 Positive culture or microimmunofluorescence of Legionella species
1934-9 Positive detection of viral antigen or antibody
1928-1 Positive dipstick for leukocyte esterase or nitrate
1943-0 Positive Gram stain when culture is negative or not done
1950-5 Positive microimmunofluorescence test for Chlamydia
1949-7 Positive PCR for Chlamydia or Mycoplasma
1947-1 Positive quantitative culture from lower respiratory tract (LRT) specimen
2345-0 Possible ventilator-associated pneumonia (PVAP)
1323-5 Post-discharge patient letter
1324-3 Post-discharge patient phone call
1322-7 Post-discharge surgeon survey
1505-7 Post-discharge surveillance
2406-7 Primary
2133-7 Prostate surgery
3059-3 Pus present at vascular specimen collection site and matching organism identified in blood and from site-specific specimen(s)
2305-1 Pus, redness, or increased swelling
1921-6 Rales or bronchial breath sounds
2518-9 Rash not otherwise specified
1517-2 Readmission to facility other than where procedure was performed
1516-4 Readmission to facility where procedure was performed
2504-9 Received non-irradiated blood in the 2 months preceding the reaction
3071-8 Recognized pathogen from cerebrospinal fluid specimen
1951-3 Recognized pathogen from one or more blood cultures
3104-7 Recorder was performer
2134-5 Rectal surgery
2135-2 Refusion of spine
2404-2 Removed within 48 hours prior
1329-2 Report from another facility (inpatient, health department, emergency department, etc.)
1341-7 Report No Events: Antimicrobial Resistance (AR)
3052-8 Report No Events: Dialysis: intravenous antimicrobial start
3053-6 Report No Events: Dialysis: positive blood culture
3054-4 Report No Events: Dialysis: pus, redness, or increased swelling at vascular access site
3011-4 Report No Events: ICU: CAUTI
3010-6 Report No Events: ICU: CLABSI
1338-3 Report No Events: ICU: PedVAE
3013-0 Report No Events: ICU: PedVAP
3012-2 Report No Events: ICU: VAE
3050-2 Report No Events: Infection Surveillance: C. difficile
3035-3 Report No Events: Infection Surveillance: CephR Klebsiella
3038-7 Report No Events: Infection Surveillance: CRE-E. coli
3041-1 Report No Events: Infection Surveillance: CRE-Enterobacter
3044-5 Report No Events: Infection Surveillance: CRE-Klebsiella
3047-8 Report No Events: Infection Surveillance: MDR-Acinetobacter
3029-6 Report No Events: Infection Surveillance: MRSA
1306-0 Report No Events: Infection Surveillance: MSSA
3032-0 Report No Events: Infection Surveillance: VRE
3051-0 Report No Events: LabID Event (All specimens): C. difficile
3036-1 Report No Events: LabID Event (All specimens): CephR Klebsiella
3039-5 Report No Events: LabID Event (All specimens): CRE-E. coli
3042-9 Report No Events: LabID Event (All specimens): CRE-Enterobacter
3045-2 Report No Events: LabID Event (All specimens): CRE-Klebsiella
3048-6 Report No Events: LabID Event (All specimens): MDR-Acinetobacter
3030-4 Report No Events: LabID Event (All specimens): MRSA
1307-8 Report No Events: LabID Event (All specimens): MSSA
3033-8 Report No Events: LabID Event (All specimens): VRE
3037-9 Report No Events: LabID Event (Blood specimens only): CephR Klebsiella
3040-3 Report No Events: LabID Event (Blood specimens only): CRE-E. coli
3043-7 Report No Events: LabID Event (Blood specimens only): CRE-Enterobacter
3046-0 Report No Events: LabID Event (Blood specimens only): CRE-Klebsiella
3049-4 Report No Events: LabID Event (Blood specimens only): MDR-Acinetobacter
3031-2 Report No Events: LabID Event (Blood specimens only): MRSA
1308-6 Report No Events: LabID Event (Blood specimens only): MSSA
3034-6 Report No Events: LabID Event (Blood specimens only): VRE
3016-3 Report No Events: NICU: CLABSI: 1001-1500 grams
3017-1 Report No Events: NICU: CLABSI: 1501-2500 grams
3015-5 Report No Events: NICU: CLABSI: 751-1000 grams
3018-9 Report No Events: NICU: CLABSI: over 2500 grams
3014-8 Report No Events: NICU: CLABSI: under 750 grams
1316-9 Report No Events: NICU: PedVAE: birth weight 1001-1500 grams
1317-7 Report No Events: NICU: PedVAE: birth weight 1501-2500 grams
1314-4 Report No Events: NICU: PedVAE: birth weight 751-1000 grams
1318-5 Report No Events: NICU: PedVAE: birth weight over 2500 grams
1313-6 Report No Events: NICU: PedVAE: birth weight under 750 grams
1319-3 Report No Events: NICU: PedVAE: Extremely preterm (<28 weeks)
1331-8 Report No Events: NICU: PedVAE: Moderate to late preterm (32 to <37 weeks)
1332-6 Report No Events: NICU: PedVAE: Term (>=37 weeks)
1330-0 Report No Events: NICU: PedVAE: Very preterm (28 to <32 weeks)
3021-3 Report No Events: NICU: PedVAP: 1001-1500 grams
3022-1 Report No Events: NICU: PedVAP: 1501-2500 grams
3020-5 Report No Events: NICU: PedVAP: 751-1000 grams
3023-9 Report No Events: NICU: PedVAP: over 2500 grams
3019-7 Report No Events: NICU: PedVAP: under 750 grams
3026-2 Report No Events: SCA: CAUTI
3025-4 Report No Events: SCA: PCLAB
1339-1 Report No Events: SCA: PedVAE
3028-8 Report No Events: SCA: PedVAP
3024-7 Report No Events: SCA: TCLAB
3027-0 Report No Events: SCA: VAE
1796-2 Reproductive tract infection
1370-6 Resident admissions
1369-8 Resident days
1375-5 Resident on antibiotic therapy for this specific organism at the time of transfer
1374-8 Resident transferred from acute care facility in past 4 weeks
1321-9 Review of patient’s medical record
1239-3 Revision associated with prior infection at index joint
1653-5 Routine follow-up at outpatient facility
3192-2 Seasons immunized
3111-2 Secondary bloodstream infection
2102-2 Shunt for dialysis
1968-7 Sinus tract
2321-8 Site of non-tunneled central line, dialysis
2322-6 Site of tunneled central line, dialysis
2136-0 Small bowel surgery
1677-4 Soft tissue, muscle, lymph node, or salivary gland infection
3114-6 Solution(s) had dried
1619-6 Spinal abscess without meningitis
2137-8 Spinal fusion
2138-6 Spleen surgery
1238-5 Surgical site infection (SSI) detected using the NHSN ICD-code based admit and readmit SSI surveillance toolkit
6113-5 Sterile gloves
6111-9 Sterile gown
1884-6 Summary data reporting active surveillance testing (AST)
2410-9 Summary data reporting antimicrobial resistance patterns at a facility
1887-9 Summary data reporting antimicrobial usage
1879-6 Summary data reporting catheter and ventilator use in a ICU/other
1881-2 Summary data reporting catheter and ventilator use in a NICU
1880-4 Summary data reporting catheter and ventilator use in a SCA
1891-1 Summary data reporting MDRO and CDI LabID Event for LTCF
1657-6 Summary data reporting outpatient procedure component events at a facility
2316-8 Summary data reporting vascular access types for chronic hemodialysis patients
1620-4 Superficial incisional primary surgical site infection (SSI)
1621-2 Superficial incisional secondary surgical site infection (SSI)
1328-4 Surgeon contacts facility to report
1625-3 Symptomatic UTI (SUTI)
2348-1 Temperature >38°C or <36°C
1005-8 Temporary central line
1337-5 Term (>=37 weeks)
2139-4 Thoracic surgery
2140-2 Thyroid and/or parathyroid surgery
1870-5 Timing of active surveillance testing (AST)
5105-2 To address a new indication for a central line
5107-8 To replace an existing central line where infection was suspected
5106-0 To replace an existing, malfunctioning central line
3538-6 Total crossmatch procedures
1644-4 Total number of admissions with a primary CPT code in this procedure category
3432-2 Total number of aliquots transfused: Plasma: Apheresis
3530-3 Total number of aliquots transfused: Plasma: Apheresis: Psoralen- and Riboflavin-treated
3430-6 Total number of aliquots transfused: Plasma: Whole blood-derived
3521-2 Total number of aliquots transfused: Plasma: Whole blood-derived: Psoralen- and Riboflavin-treated
3422-3 Total number of aliquots transfused: Platelets: Apheresis
3512-1 Total number of aliquots transfused: Platelets: Apheresis: Psoralen- and Riboflavin-treated
3410-8 Total number of aliquots transfused: Red Blood Cells: Apheresis
3554-3 Total number of aliquots transfused: Red Blood Cells: Apheresis: S-303- and Riboflavin-treated
3402-5 Total number of aliquots transfused: Red Blood Cells: Whole blood-derived
3545-1 Total number of aliquots transfused: Red Blood Cells: Whole blood-derived: S-303- and Riboflavin-treated
3468-6 Total number of aliquots transfused: Whole Blood
3501-4 Total number of discards: Cryoprecipitate
3563-4 Total number of discards: Cryoprecipitate: Psoralen- and Riboflavin-treated
3500-6 Total number of discards: Plasma: Apheresis
3531-1 Total number of discards: Plasma: Apheresis: Psoralen- and Riboflavin-treated
3497-5 Total number of discards: Plasma: Whole blood-derived
3522-0 Total number of discards: Plasma: Whole blood-derived: Psoralen- and Riboflavin-treated
3490-0 Total number of discards: Platelets: Apheresis
3513-9 Total number of discards: Platelets: Apheresis: Psoralen- and Riboflavin-treated
3484-3 Total number of discards: Platelets: Whole blood-derived
3504-8 Total number of discards: Platelets: Whole blood-derived: Psoralen- and Riboflavin-treated
3477-7 Total number of discards: Red Blood Cells: Apheresis
3555-0 Total number of discards: Red Blood Cells: Apheresis: S-303- and Riboflavin-treated
3470-2 Total number of discards: Red Blood Cells: Whole blood-derived
3546-9 Total number of discards: Red Blood Cells: Whole blood-derived: S-303- and Riboflavin-treated
3469-4 Total number of discards: Whole Blood
3433-0 Total number of units transfused: Cryoprecipitate
3562-6 Total number of units transfused: Cryoprecipitate: Psoralen- and Riboflavin-treated
3431-4 Total number of units transfused: Plasma: Apheresis
3529-5 Total number of units transfused: Plasma: Apheresis: Psoralen- and Riboflavin-treated
3429-8 Total number of units transfused: Plasma: Whole blood-derived
3520-4 Total number of units transfused: Plasma: Whole blood-derived: Psoralen- and Riboflavin-treated
3421-5 Total number of units transfused: Platelets: Apheresis
3511-3 Total number of units transfused: Platelets: Apheresis: Psoralen- and Riboflavin-treated
3417-3 Total number of units transfused: Platelets: Whole blood-derived
3502-2 Total number of units transfused: Platelets: Whole blood-derived: Psoralen- and Riboflavin-treated
3409-0 Total number of units transfused: Red Blood Cells: Apheresis
3553-5 Total number of units transfused: Red Blood Cells: Apheresis: S-303- and Riboflavin-treated
3401-7 Total number of units transfused: Red Blood Cells: Whole blood-derived
3544-4 Total number of units transfused: Red Blood Cells: Whole blood-derived: S-303- and Riboflavin-treated
3467-8 Total number of units transfused: Whole Blood
3539-4 Total patients transfused
2036-2 Toxigenic culture
2304-4 Transient patient
1117-1 Tunneled (dialysis)
1118-9 Tunneled (other than dialysis)
1116-3 Umbilical
1622-0 Upper respiratory tract infection, pharyngitis, laryngitis, epiglottitis
3191-4 Urinary catheter present
1972-9 Urine not tested for white blood cells
1624-6 Vaginal cuff infection
2141-0 Vaginal hysterectomy
2319-2 Vascular access
2323-4 Vascular site fistula
2324-2 Vascular site graft
2343-4 Ventilator-associated condition (VAC)
2340-3 Ventilator-associated event (VAE)
2142-8 Ventricular shunt
2053-7 Verona integron-encoded metallo-beta-lactamase
1606-3 Vertebral disc space infection
1335-9 Very preterm (28 to <32 weeks)
1922-4 Wheezing, rales or rhonchi
2331-7 Where was the positive blood culture collected
2349-9 White blood cell count >=12,000 or <=4,000 cells/mm3
1958-8 Worsening gas exchange
2320-0 Wound (not related to vascular access) with pus or increased redness
1649-3 Wrong implant
1648-5 Wrong patient
1647-7 Wrong side
1646-9 Wrong site